Popov S V, Mazo E B
Urologiia. 2008 May-Jun(3):36, 38-41.
A total of 20 patients entered the clinical trial of efficacy and safety of Russian produced drug levofloxacin (floracid) in the treatment of chronic bacterial prostatitis (CBP). The drug was given in a single dose of 500 mg/day for 28 days. Antibacterial treatment of CBP with floracid killed sensitive to it bacteria in 18 of 20 (90%) CBP patients. Symptoms of the disease attenuated including pain syndrome and voiding disorders, quality of life assessed by NIH-CPSI scale improved. The absence of side effects points to good tolerance and safety of the drug.
共有20名患者参与了俄罗斯生产的药物左氧氟沙星（氟罗沙星）治疗慢性细菌性前列腺炎（CBP）的疗效和安全性临床试验。该药物以每日500毫克的单剂量给药，持续28天。用氟罗沙星对CBP进行抗菌治疗，在20名CBP患者中有18名（90%）的敏感细菌被杀死。疾病症状减轻，包括疼痛综合征和排尿障碍，通过NIH-CPSI量表评估的生活质量得到改善。未出现副作用表明该药物耐受性良好且安全。
